Logo image of CMBT.BR

CMB TECH NV (CMBT.BR) Stock Fundamental Analysis

EBR:CMBT - Euronext Brussels - BE0003816338 - Common Stock - Currency: EUR

8.6  +0.29 (+3.49%)

Fundamental Rating

4

Taking everything into account, CMBT scores 4 out of 10 in our fundamental rating. CMBT was compared to 60 industry peers in the Oil, Gas & Consumable Fuels industry. While CMBT has a great profitability rating, there are quite some concerns on its financial health. CMBT has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year CMBT was profitable.
CMBT had a positive operating cash flow in the past year.
Of the past 5 years CMBT 4 years were profitable.
Of the past 5 years CMBT 4 years had a positive operating cash flow.
CMBT.BR Yearly Net Income VS EBIT VS OCF VS FCFCMBT.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M

1.2 Ratios

The Return On Assets of CMBT (37.49%) is better than 96.67% of its industry peers.
With an excellent Return On Equity value of 122.80%, CMBT belongs to the best of the industry, outperforming 98.33% of the companies in the same industry.
The Return On Invested Capital of CMBT (11.69%) is better than 71.67% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CMBT is below the industry average of 11.93%.
The last Return On Invested Capital (11.69%) for CMBT is above the 3 year average (8.95%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 37.49%
ROE 122.8%
ROIC 11.69%
ROA(3y)17.5%
ROA(5y)11.27%
ROE(3y)39.6%
ROE(5y)24.4%
ROIC(3y)8.95%
ROIC(5y)N/A
CMBT.BR Yearly ROA, ROE, ROICCMBT.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

1.3 Margins

With an excellent Profit Margin value of 104.40%, CMBT belongs to the best of the industry, outperforming 98.33% of the companies in the same industry.
In the last couple of years the Profit Margin of CMBT has grown nicely.
CMBT's Operating Margin of 39.03% is fine compared to the rest of the industry. CMBT outperforms 78.33% of its industry peers.
In the last couple of years the Operating Margin of CMBT has grown nicely.
CMBT has a Gross Margin of 60.19%. This is in the better half of the industry: CMBT outperforms 66.67% of its industry peers.
In the last couple of years the Gross Margin of CMBT has remained more or less at the same level.
Industry RankSector Rank
OM 39.03%
PM (TTM) 104.4%
GM 60.19%
OM growth 3YN/A
OM growth 5Y14.72%
PM growth 3YN/A
PM growth 5Y49.82%
GM growth 3Y46.27%
GM growth 5Y-0.15%
CMBT.BR Yearly Profit, Operating, Gross MarginsCMBT.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CMBT is creating some value.
Compared to 1 year ago, CMBT has less shares outstanding
Compared to 5 years ago, CMBT has less shares outstanding
The debt/assets ratio for CMBT is higher compared to a year ago.
CMBT.BR Yearly Shares OutstandingCMBT.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CMBT.BR Yearly Total Debt VS Total AssetsCMBT.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

Based on the Altman-Z score of 1.55, we must say that CMBT is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of CMBT (1.55) is comparable to the rest of the industry.
A Debt/Equity ratio of 1.94 is on the high side and indicates that CMBT has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.94, CMBT is doing worse than 88.33% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.94
Debt/FCF N/A
Altman-Z 1.55
ROIC/WACC1.58
WACC7.38%
CMBT.BR Yearly LT Debt VS Equity VS FCFCMBT.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

2.3 Liquidity

A Current Ratio of 0.78 indicates that CMBT may have some problems paying its short term obligations.
The Current ratio of CMBT (0.78) is worse than 88.33% of its industry peers.
CMBT has a Quick Ratio of 0.78. This is a bad value and indicates that CMBT is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.71, CMBT is not doing good in the industry: 90.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.78
Quick Ratio 0.71
CMBT.BR Yearly Current Assets VS Current LiabilitesCMBT.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

4

3. Growth

3.1 Past

CMBT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -13.35%.
Measured over the past years, CMBT shows a very strong growth in Earnings Per Share. The EPS has been growing by 43.41% on average per year.
The Revenue for CMBT has decreased by -24.33% in the past year. This is quite bad
CMBT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.55% yearly.
EPS 1Y (TTM)-13.35%
EPS 3YN/A
EPS 5Y43.41%
EPS Q2Q%-94.58%
Revenue 1Y (TTM)-24.33%
Revenue growth 3Y30.84%
Revenue growth 5Y0.55%
Sales Q2Q%-58.68%

3.2 Future

The Earnings Per Share is expected to decrease by -29.06% on average over the next years. This is quite bad
CMBT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.37% yearly.
EPS Next Y-69.07%
EPS Next 2Y-32.88%
EPS Next 3Y-29.06%
EPS Next 5YN/A
Revenue Next Year7.15%
Revenue Next 2Y15.37%
Revenue Next 3Y9.37%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CMBT.BR Yearly Revenue VS EstimatesCMBT.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
CMBT.BR Yearly EPS VS EstimatesCMBT.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4

5

4. Valuation

4.1 Price/Earnings Ratio

CMBT is valuated cheaply with a Price/Earnings ratio of 2.65.
Compared to the rest of the industry, the Price/Earnings ratio of CMBT indicates a rather cheap valuation: CMBT is cheaper than 95.00% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 28.88, CMBT is valued rather cheaply.
CMBT is valuated reasonably with a Price/Forward Earnings ratio of 8.55.
The rest of the industry has a similar Price/Forward Earnings ratio as CMBT.
CMBT is valuated cheaply when we compare the Price/Forward Earnings ratio to 21.20, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 2.65
Fwd PE 8.55
CMBT.BR Price Earnings VS Forward Price EarningsCMBT.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

61.67% of the companies in the same industry are cheaper than CMBT, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.64
CMBT.BR Per share dataCMBT.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

CMBT has a very decent profitability rating, which may justify a higher PE ratio.
CMBT's earnings are expected to decrease with -29.06% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.06
EPS Next 2Y-32.88%
EPS Next 3Y-29.06%

0

5. Dividend

5.1 Amount

CMBT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CMB TECH NV

EBR:CMBT (4/30/2025, 7:00:00 PM)

8.6

+0.29 (+3.49%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)02-27 2025-02-27/bmo
Earnings (Next)05-14 2025-05-14/bmo
Inst Owners1.58%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.89B
Analysts76.67
Price Target12.23 (42.21%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend5
Dividend Growth(5Y)116.35%
DP76.95%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-26.64%
Min EPS beat(2)-49.61%
Max EPS beat(2)-3.67%
EPS beat(4)2
Avg EPS beat(4)129.78%
Min EPS beat(4)-49.61%
Max EPS beat(4)330.29%
EPS beat(8)6
Avg EPS beat(8)107.97%
EPS beat(12)9
Avg EPS beat(12)83.68%
EPS beat(16)11
Avg EPS beat(16)63.65%
Revenue beat(2)2
Avg Revenue beat(2)8.74%
Min Revenue beat(2)6.27%
Max Revenue beat(2)11.21%
Revenue beat(4)3
Avg Revenue beat(4)7.71%
Min Revenue beat(4)-1.97%
Max Revenue beat(4)15.33%
Revenue beat(8)7
Avg Revenue beat(8)31.11%
Revenue beat(12)11
Avg Revenue beat(12)39.61%
Revenue beat(16)15
Avg Revenue beat(16)45.07%
PT rev (1m)-9.01%
PT rev (3m)-23.1%
EPS NQ rev (1m)0%
EPS NQ rev (3m)68.46%
EPS NY rev (1m)0%
EPS NY rev (3m)-27.55%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.55%
Revenue NY rev (1m)-1.72%
Revenue NY rev (3m)-11.57%
Valuation
Industry RankSector Rank
PE 2.65
Fwd PE 8.55
P/S 1.53
P/FCF N/A
P/OCF 4.69
P/B 1.8
P/tB 1.83
EV/EBITDA 6.64
EPS(TTM)3.25
EY37.79%
EPS(NY)1.01
Fwd EY11.7%
FCF(TTM)-2.65
FCFYN/A
OCF(TTM)1.83
OCFY21.33%
SpS5.6
BVpS4.76
TBVpS4.7
PEG (NY)N/A
PEG (5Y)0.06
Profitability
Industry RankSector Rank
ROA 37.49%
ROE 122.8%
ROCE 15.59%
ROIC 11.69%
ROICexc 11.82%
ROICexgc 11.88%
OM 39.03%
PM (TTM) 104.4%
GM 60.19%
FCFM N/A
ROA(3y)17.5%
ROA(5y)11.27%
ROE(3y)39.6%
ROE(5y)24.4%
ROIC(3y)8.95%
ROIC(5y)N/A
ROICexc(3y)9.88%
ROICexc(5y)N/A
ROICexgc(3y)9.93%
ROICexgc(5y)N/A
ROCE(3y)11.93%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y15.98%
ROICexc growth 3YN/A
ROICexc growth 5Y15.87%
OM growth 3YN/A
OM growth 5Y14.72%
PM growth 3YN/A
PM growth 5Y49.82%
GM growth 3Y46.27%
GM growth 5Y-0.15%
F-Score4
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 1.94
Debt/FCF N/A
Debt/EBITDA 3.25
Cap/Depr 675.47%
Cap/Sales 79.96%
Interest Coverage 5.02
Cash Conversion 64.34%
Profit Quality N/A
Current Ratio 0.78
Quick Ratio 0.71
Altman-Z 1.55
F-Score4
WACC7.38%
ROIC/WACC1.58
Cap/Depr(3y)357.13%
Cap/Depr(5y)252.34%
Cap/Sales(3y)69.97%
Cap/Sales(5y)65.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-13.35%
EPS 3YN/A
EPS 5Y43.41%
EPS Q2Q%-94.58%
EPS Next Y-69.07%
EPS Next 2Y-32.88%
EPS Next 3Y-29.06%
EPS Next 5YN/A
Revenue 1Y (TTM)-24.33%
Revenue growth 3Y30.84%
Revenue growth 5Y0.55%
Sales Q2Q%-58.68%
Revenue Next Year7.15%
Revenue Next 2Y15.37%
Revenue Next 3Y9.37%
Revenue Next 5YN/A
EBIT growth 1Y-39.07%
EBIT growth 3YN/A
EBIT growth 5Y15.35%
EBIT Next Year60.32%
EBIT Next 3Y20.22%
EBIT Next 5YN/A
FCF growth 1Y-232.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-45.18%
OCF growth 3YN/A
OCF growth 5Y11.04%